![](/img/cover-not-exists.png)
Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration
CHRIS J. TYRRElL, PETER IVERSEN, TEUVO TAMMELA, JOHN ANDERSON, THOMAS BJÖRK, AMIR V. KAISARY, THOMAS MORRISVolume:
98
Year:
2006
Language:
english
Pages:
10
DOI:
10.1111/j.1464-410x.2006.06275.x
File:
PDF, 179 KB
english, 2006